Executive Director Diversity and Inclusion in Clinical Trials, Eli Lilly and Company, United States
Leader with over 30 years in the pharmaceutical sector spanning discovery, New Product Planning, late-stage development, and COVID-19 Ab program. Current focus is on crafting strategies that bolster awareness, education, and availability of CTs for underrepresented groups worldwide...
Read More →